<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>FeedChannel</itunes:name>
            <itunes:email>feedchannel@feedchannel.online</itunes:email>
        </itunes:owner>
        <title>FeedChannel</title>
        <link>https://www.feedchannel.online</link>
        <description></description>
        <language>en-us</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>FeedChannel</itunes:author>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://www.feedchannel.online/files/rv1.7/sitelogo.gif"/>
        <image>
            <url>https://www.feedchannel.online/files/rv1.7/sitelogo.gif</url>
            <title>FeedChannel</title>
            <link>https://www.feedchannel.online</link>
        </image>
        <atom:link rel="self" href="https://www.feedchannel.online/podcast/tag/ prediction"/>
        <atom:link rel="next" href="https://www.feedchannel.online/podcast/tag/ prediction?tag=+prediction&amp;p=2&amp;podcast%5fp=t&amp;https="/>
        <item>
            <enclosure url="http://www.feedchannel.online/64968578/67502508/6e4d9767808b33824e2b08ec6330b6c3/video_medium/1320-for-both-of-you-jean-and-video.mp4?source=podcast" type="video/mp4" length="6405416"/>
            <title>#13/20 - For both of you, Jean and Pierre can you summarize what could be the...</title>
            <link>http://www.feedchannel.online/1320-for-both-of-you-jean-and</link>
            <description>&lt;p&gt;&lt;div&gt;&lt;b&gt;Speakers:&lt;/b&gt; Dr Jean Noblet, Dr Pierre-André Geraert and Pierre Cozannet&amp;nbsp;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Answer:&lt;/b&gt;&lt;br&gt;The first benefit of moving from DE/ME to Net energy is to get a more precise and a more representative energy predictors or energy estimation of the true energy value of the feed.&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Q&amp;amp;A #13/20_Webinar #11)&lt;/b&gt;&lt;/div&gt;&lt;div&gt;After education on Net Energy in the&amp;nbsp;&lt;a&gt;SEV&lt;/a&gt;, time now to get our expert, Jean Noblet answering questions from the field. The short introduction will be followed by 17 questions answered by Jean, Pierre Cozannet with Pierre-André Geraert as moderator of the webinar.&lt;br&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.feedchannel.online/1320-for-both-of-you-jean-and"&gt;&lt;img src="http://www.feedchannel.online/64968578/67502508/6e4d9767808b33824e2b08ec6330b6c3/standard/download-5-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://www.feedchannel.online/photo/67502508</guid>
            <pubDate>Wed, 14 Oct 2020 00:00:00 GMT</pubDate>
            <media:title>#13/20 - For both of you, Jean and Pierre can you summarize what could be the...</media:title>
            <itunes:summary>Speakers: Dr Jean Noblet, Dr Pierre-André Geraert and Pierre CozannetAnswer:The first benefit of moving from DE/ME to Net energy is to get a more precise and a more representative energy predictors or energy estimation of the true energy value of the feed.QA #13/20_Webinar #11)After education on Net Energy in theSEV, time now to get our expert, Jean Noblet answering questions from the field. The short introduction will be followed by 17 questions answered by Jean, Pierre Cozannet with Pierre-André Geraert as moderator of the webinar.</itunes:summary>
            <itunes:subtitle>Speakers: Dr Jean Noblet, Dr Pierre-André Geraert and Pierre CozannetAnswer:The first benefit of moving from DE/ME to Net energy is to get a more precise and a more representative energy predictors or energy estimation of the true energy value of...</itunes:subtitle>
            <itunes:author>FeedChannel</itunes:author>
            <itunes:duration>04:39</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;div&gt;&lt;b&gt;Speakers:&lt;/b&gt; Dr Jean Noblet, Dr Pierre-André Geraert and Pierre Cozannet&amp;nbsp;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Answer:&lt;/b&gt;&lt;br&gt;The first benefit of moving from DE/ME to Net energy is to get a more precise and a more representative energy predictors or energy estimation of the true energy value of the feed.&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Q&amp;amp;A #13/20_Webinar #11)&lt;/b&gt;&lt;/div&gt;&lt;div&gt;After education on Net Energy in the&amp;nbsp;&lt;a&gt;SEV&lt;/a&gt;, time now to get our expert, Jean Noblet answering questions from the field. The short introduction will be followed by 17 questions answered by Jean, Pierre Cozannet with Pierre-André Geraert as moderator of the webinar.&lt;br&gt;&lt;/div&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.feedchannel.online/1320-for-both-of-you-jean-and"&gt;&lt;img src="http://www.feedchannel.online/64968578/67502508/6e4d9767808b33824e2b08ec6330b6c3/standard/download-5-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//www.feedchannel.online/v.ihtml/player.html?token=6e4d9767808b33824e2b08ec6330b6c3&amp;source=podcast&amp;photo%5fid=67502508" width="625" height="352" type="text/html" medium="video" duration="279" isDefault="true" expression="full"/>
            <media:thumbnail url="http://www.feedchannel.online/64968578/67502508/6e4d9767808b33824e2b08ec6330b6c3/standard/download-5-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://www.feedchannel.online/64968578/67502508/6e4d9767808b33824e2b08ec6330b6c3/standard/download-5-thumbnail.jpg/thumbnail.jpg"/>
            <category>AME</category>
            <category> CP</category>
            <category> low proteins</category>
            <category> metabolizable</category>
            <category> NE</category>
            <category> net energy</category>
            <category> precision</category>
            <category> prediction</category>
            <category> Q&amp;A</category>
            <category> sustainability</category>
            <category> webinar</category>
        </item>
        <item>
            <enclosure url="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/video_medium/antibiotics-probiotics-and-video.mp4?source=podcast" type="video/mp4" length="83207939"/>
            <title>Antibiotics, probiotics and anti-virulence: balancing efficacy and evolution</title>
            <link>http://www.feedchannel.online/antibiotics-probiotics-and</link>
            <description>&lt;p&gt;&lt;b&gt;Speaker: &lt;/b&gt;Prof Sam BROWN, Georgia Institute of Technology, USA &lt;br&gt;&lt;br&gt;Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;6th international Conference on Poultry Intestinal Health (IHSIG)&lt;/b&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.feedchannel.online/antibiotics-probiotics-and"&gt;&lt;img src="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/standard/download-4-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://www.feedchannel.online/photo/66498938</guid>
            <pubDate>Tue, 02 Jul 2019 00:00:00 GMT</pubDate>
            <media:title>Antibiotics, probiotics and anti-virulence: balancing efficacy and evolution</media:title>
            <itunes:summary>Speaker: Prof Sam BROWN, Georgia Institute of Technology, USA Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.6th international Conference on Poultry Intestinal Health (IHSIG)</itunes:summary>
            <itunes:subtitle>Speaker: Prof Sam BROWN, Georgia Institute of Technology, USA Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more...</itunes:subtitle>
            <itunes:author>FeedChannel</itunes:author>
            <itunes:duration>38:08</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;b&gt;Speaker: &lt;/b&gt;Prof Sam BROWN, Georgia Institute of Technology, USA &lt;br&gt;&lt;br&gt;Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;6th international Conference on Poultry Intestinal Health (IHSIG)&lt;/b&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.feedchannel.online/antibiotics-probiotics-and"&gt;&lt;img src="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/standard/download-4-thumbnail.jpg" width="600" height="338"/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="//www.feedchannel.online/v.ihtml/player.html?token=1ff0220a91af059f1d1040affc0b87cd&amp;source=podcast&amp;photo%5fid=66498938" width="625" height="352" type="text/html" medium="video" duration="2288" isDefault="true" expression="full"/>
            <media:thumbnail url="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/standard/download-4-thumbnail.jpg" width="600" height="338"/>
            <itunes:image href="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/standard/download-4-thumbnail.jpg/thumbnail.jpg"/>
            <category>alternate states</category>
            <category>antibiotics</category>
            <category>anti-resistance</category>
            <category>anti-virulence drugs</category>
            <category>asymptomatic</category>
            <category>carriage states</category>
            <category>chronic infections</category>
            <category>conditional strategies</category>
            <category>cooperative virulence</category>
            <category>cystic fibrosis</category>
            <category>efficacy</category>
            <category>evolution-proof</category>
            <category>gallium</category>
            <category>IHSIG</category>
            <category>microbiomes</category>
            <category>models</category>
            <category>prediction</category>
            <category>resistance</category>
            <category>robustness</category>
            <category>symptoms</category>
            <category>synthetic communities</category>
            <category>transitions</category>
            <category>treatments</category>
        </item>
    </channel>
</rss>
